Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intrathecal therapy in tetanus. A meta-analysis.

E Abrutyn1, J A Berlin

  • 1Medical College of Pennsylvania, Veterans Affairs Medical Center, Section in Infectious Diseases, Philadelphia.

JAMA
|October 23, 1991
PubMed
Summary

Intrathecal tetanus antibody therapy shows no proven benefit for neonatal or adult tetanus. Further research is needed to establish efficacy and safety of antitetanus equine serum and human tetanus immune globulin.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus.

Diabetes, obesity & metabolism·2012
Same author

The accuracy of substitution rules for health risk appraisals.

American journal of health promotion : AJHP·2011
Same author

Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes.

British journal of cancer·2010
Same author

Analyses of mortality risk in patients with dementia treated with galantamine.

Acta neurologica Scandinavica·2008
Same author

Outcomes with daptomycin versus standard therapy for osteoarticular infections associated with Staphylococcus aureus bacteraemia.

The Journal of antimicrobial chemotherapy·2007
Same author

Pharmacogenetic modulation of combined hormone replacement therapy by progesterone-metabolism genotypes in postmenopausal breast cancer risk.

American journal of epidemiology·2007

Area of Science:

  • Neurology
  • Infectious Diseases
  • Immunology

Background:

  • Tetanus remains a significant global health concern, particularly in neonates and adults.
  • Intrathecal administration of tetanus antibodies is a potential therapeutic approach.
  • Evidence regarding its efficacy is limited and requires rigorous evaluation.

Purpose of the Study:

  • To systematically evaluate the efficacy of intrathecal tetanus antibody therapy.
  • To assess treatment outcomes in both neonatal and adult tetanus cases.
  • To utilize meta-analytical techniques for robust evidence synthesis.

Main Methods:

  • Comprehensive literature search of MEDLINE and bibliographies.
  • Inclusion of English-language clinical trials with concurrent controls.
  • Data extraction and verification by two independent reviewers.

Main Results:

  • No significant treatment effect observed in neonatal tetanus across all studies.
  • A potential benefit of antitetanus equine serum in adult tetanus, though requiring cautious interpretation.
  • Limited power for subgroup analyses and common methodological challenges in trials.
  • Safety of intrathecal tetanus antibody therapy remains unestablished.

Conclusions:

  • Intrathecal therapy for tetanus lacks proven benefit.
  • Antitetanus equine serum and human tetanus immune globulin should be administered cautiously.
  • Future use should be restricted to well-designed, controlled clinical trials.

Related Experiment Videos